Skip Navigation


The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients.

Bookmark | Print | E-Mail

Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Cardiology/Vascular Diseases

Peripheral Vascular Disease

California

Santa Ana : Apex Research Institute

Why Do My Legs Hurt? You may have Peripheral Arterial Disease

Georgia

Atlanta : Emory Surgery Research

A six-month study using an FDA approved high blood pressure medication to evaluate its usefulness in lower leg circulation problems (intermittent claudication)

New Jersey

Morristown : Atlantic Health System New!

Safety and Effectiveness Study of EverFlex Stent to Treat Symptomatic Femoral-Popliteal Atherosclerosis (DURABILITY II)

Belgium

Gent : Research Site:

A Study of NT-Pro-Brain Peptide (NT-proBNP) in Patients Scheduled for Major Vascular Surgery.

Leuven : Research Site:

A Study of NT-Pro-Brain Peptide (NT-proBNP) in Patients Scheduled for Major Vascular Surgery.

Brazil

Sao Paulo : Research Site:

A Study of NT-Pro-Brain Peptide (NT-proBNP) in Patients Scheduled for Major Vascular Surgery.

France

Besancon : Research Site:

A Study of NT-Pro-Brain Peptide (NT-proBNP) in Patients Scheduled for Major Vascular Surgery.

Ireland

Dublin : Research Site:

A Study of NT-Pro-Brain Peptide (NT-proBNP) in Patients Scheduled for Major Vascular Surgery.

Italy

Florence : Research Site:

A Study of NT-Pro-Brain Peptide (NT-proBNP) in Patients Scheduled for Major Vascular Surgery.

Netherlands

Arnhem : Research Site:

A Study of NT-Pro-Brain Peptide (NT-proBNP) in Patients Scheduled for Major Vascular Surgery.

Beverwijk : Research Site:

A Study of NT-Pro-Brain Peptide (NT-proBNP) in Patients Scheduled for Major Vascular Surgery.

Heerlen : Research Site:

A Study of NT-Pro-Brain Peptide (NT-proBNP) in Patients Scheduled for Major Vascular Surgery.

Hoogeveen : Research Site:

A Study of NT-Pro-Brain Peptide (NT-proBNP) in Patients Scheduled for Major Vascular Surgery.

Nieuwegein : Research Site:

A Study of NT-Pro-Brain Peptide (NT-proBNP) in Patients Scheduled for Major Vascular Surgery.

Nijmegen : Research Site:

A Study of NT-Pro-Brain Peptide (NT-proBNP) in Patients Scheduled for Major Vascular Surgery.

Rotterdam : Research Site:

A Study of NT-Pro-Brain Peptide (NT-proBNP) in Patients Scheduled for Major Vascular Surgery.

Zwolle : Research Site:

A Study of NT-Pro-Brain Peptide (NT-proBNP) in Patients Scheduled for Major Vascular Surgery.

Poland

Wroclaw : Research Site:

A Study of NT-Pro-Brain Peptide (NT-proBNP) in Patients Scheduled for Major Vascular Surgery.

Serbia and Montenegro

Belgrade : Research Site:

A Study of NT-Pro-Brain Peptide (NT-proBNP) in Patients Scheduled for Major Vascular Surgery.


Jobson Medical Information

Copyright © 1995-2009 Jobson Medical Information LLC.


Designed by Piehead Productions LLC.